Natus Medical, Inc. (BABY) Misses Q4 EPS by 1c, Offers Q1 and FY12 Outlook

February 28, 2012 7:08 AM EST
Get Alerts BABY Hot Sheet
Price: $26.75 --0%

Financial Fact:
Cost of revenue: 32.19M

Today's EPS Names:
EGRX, MOVE, MDRX, More
Join SI Premium – FREE
Natus Medical, Inc. (NASDAQ: BABY) reported Q4 EPS of $0.14, $0.01 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $64.1 million versus the consensus estimate of $64.97 million.

Natus Medical, Inc. sees Q1 2012 EPS of $0.00-$0.07, versus the consensus of $0.07. Natus Medical, Inc. sees Q1 2012 revenue of $55-$60 million, versus the consensus of $60.2 million.

Natus Medical, Inc. sees FY2012 EPS of $0.57-$0.62, versus the consensus of $0.60. Natus Medical, Inc. sees FY2012 revenue of $256-$262 million, versus the consensus of $260.37 million.

For earnings history and earnings-related data on Natus Medical, Inc. (BABY) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings